Maria Carvajal Perea: Prothrombin Complex Concentrate vs Plasma – Optimizing Hemostasis After Cardiac Surgery
Maria Carvajal Perea, Basic Life Support for Healthcare Providers (BLS) at American Heart Association, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Colombian Journal of Anesthesiology, adding:
“I am thrilled to share the publication of my first scientific article as a co-author in the Colombian Journal of Anesthesiology!
‘Prothrombin complex concentrate versus plasma for coagulopathic bleeding after cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis.’
Managing coagulopathic bleeding after cardiac surgery requires rapid, evidence-based decisions. In this systematic review and meta-analysis, our team prioritized clinically relevant hemostatic outcomes rather than relying solely on surrogate laboratory markers.
Main Findings from Meta-Analysis:
- Hemostatic Control: Prothrombin complex concentrate (PCC) significantly reduced clinically relevant hemostatic failure compared to plasma strategies (RR 0.55; 95% CI 0.42–0.70).
- Renal Protection: PCC was associated with a lower risk of acute kidney injury (RR 0.57; 95% CI 0.35–0.91).
- Safety Profile: While results are promising, larger studies are still needed to more precisely define safety conclusions regarding thromboembolic events and mortality.
Being part of this inter-institutional project has been an incredibly valuable learning experience, further strengthening my commitment to research, academic medicine, and anesthesiology.
I’m very grateful to my co-authors and the entire research team for their invaluable scholarly guidance, rigorous feedback, and collaborative effort throughout this study.
Proud to see our work published.”
Title: Prothrombin complex concentrate versus plasma for coagulopathic bleeding after cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis
Authors: Paula A. Henríquez Miranda, Betty Gabriel Valencia Angarita, María Carvajal Perea, Mayra Alejandra Parada Navarro, Valentina Moreno Goyeneche, María Camila Madariaga Estupiñán

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 19, 2026, 07:00Rucha Patil: Highlights in Science and Collaboration at Haematocon 2026
-
Nov 19, 2026, 06:20Suvro Sankha Datta: AABB Releases the 8th Edition of Molecular Testing Standards
-
Nov 19, 2026, 05:54Global Collaboration in Hemostasis – ISTH
-
Nov 19, 2026, 05:40Pete Stibbs: Advancing Treatment Strategies in Venous Disease
-
Nov 19, 2026, 05:31Lance Reed: One Donation, Multiple Lives
-
Nov 19, 2026, 05:20ZPI Silencing as a Novel Non-Factor Therapy for Rare Bleeding Disorders – HITh
-
Nov 19, 2026, 04:48Antiphospholipid Antibodies and Stroke Management – RPTH
-
Nov 18, 2026, 20:58Uma Vaidyanathan: When Hemoglobin Does Not Respond to Iron Therapy, Look Beyond Iron Deficiency
-
Nov 18, 2026, 20:57Jamil Rafiq: 5 Ways to Prevent Sample Haemolysis